Biomea Fusion, Inc. Earnings Per Share, Basic and Diluted
Biomea Fusion, Inc. (BMEA) reported Earnings Per Share, Basic and Diluted of -$0.59 per share for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-01.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-08-01
- Biomea Fusion, Inc. earnings per share, basic and diluted for the quarter ending 2022-06-30 was -$0.59.
- Biomea Fusion, Inc. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.56.
- Biomea Fusion, Inc. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.51.
- Biomea Fusion, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.43.
- Biomea Fusion, Inc. earnings per share, basic and diluted for fiscal 2021 was -$1.74.
- Biomea Fusion, Inc. earnings per share, basic and diluted for fiscal 2020 was -$0.51.
- Biomea Fusion, Inc. earnings per share, basic and diluted for fiscal 2019 was -$0.20.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-06-30 | -$0.59 10-Q · filed 2022-08-01 | -$1.15 10-Q · filed 2022-08-01 | -$1.66 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$2.09 derived: net income ÷ weighted average shares · filed 2024-03-28 |
| 2022-03-31 | -$0.56 10-Q · filed 2022-05-16 | -$1.07 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$1.50 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$1.85 derived: net income ÷ weighted average shares · filed 2024-03-28 |
| 2021-12-31 | -$0.51 10-K · filed 2022-02-28 | -$0.94 derived: net income ÷ weighted average shares · filed 2023-03-28 | -$1.29 derived: net income ÷ weighted average shares · filed 2023-03-28 | -$1.74 10-K · filed 2022-02-28 |
| 2021-09-30 | -$0.43 10-K · filed 2022-02-28 | -$0.78 derived: net income ÷ weighted average shares · filed 2023-03-28 | -$1.21 10-Q · filed 2021-11-03 | -$1.56 derived: net income ÷ weighted average shares · filed 2023-03-28 |
| 2021-06-30 | -$0.33 10-Q · filed 2022-08-01 | -$0.77 10-Q · filed 2022-08-01 | -$1.09 derived: net income ÷ weighted average shares · filed 2023-03-28 | -$1.24 derived: net income ÷ weighted average shares · filed 2023-03-28 |
| 2021-03-31 | -$0.49 10-Q · filed 2022-05-16 | -$0.78 derived: net income ÷ weighted average shares · filed 2023-03-28 | -$0.88 derived: net income ÷ weighted average shares · filed 2023-03-28 | -$0.95 derived: net income ÷ weighted average shares · filed 2023-03-28 |
| 2020-12-31 | -$0.29 10-K · filed 2022-02-28 | -$0.39 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$0.44 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$0.51 10-K · filed 2022-02-28 |
| 2020-09-30 | -$0.10 10-K · filed 2022-02-28 | -$0.13 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$0.18 10-Q · filed 2021-11-03 | |
| 2020-06-30 | -$0.03 10-K · filed 2022-02-28 | -$0.07 10-Q · filed 2021-08-11 | ||
| 2020-03-31 | -$0.05 10-K · filed 2022-02-28 | |||
| 2019-12-31 | -$0.20 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B |